Stockreport

Visiongain Report Provides Critical Market-led Data on the $6.6bn Biosimilar Monoclonal Antibodies Market

HYPERA SA S/ADR  (HYPMY) 
NASDAQ:AMEX Investor Relations: hypera.riweb.com.br/default.aspx?linguagem=en
PDF LONDON, April 10, 2020 /PRNewswire/ -- The global biosimilar monoclonal antibodies market is expected to grow at a CAGR of 9.6% in the second half of the forecast period [Read more]